A published study suggested that injection of a SOD1 enzyme produced by Bacillus amyloliquefaciens into dextransulfatesodium (DSS)-treated SOD1 knockout mice could prevent colitis by inhibiting p38 mitogen-activated protein kinase (MAPK)/NF-κB signaling [50]. The gene discussed is SOD1; the disease is colitis.